Maryland heat deaths, illnesses already above 2024 rates
In 2024, there were 27 heat-related deaths across the state, according to reports from the state Department of Health. By late July last year, 11 people had died.
During Maryland's heat season, which the department defines as May through September, there have already been 1,008 EMS calls and 1,129 emergency department or urgent care visits related to heat-related illness in 2025.
Despite two more months of heat season, Maryland is close to meeting last year's total number of emergency department or urgent care visits because of heat, which was 1,206 in 2024.
'Heat illness is certainly an under-recognized, under-appreciated threat, and it can have real consequences,' said David Gatz, the associate medical director of the Adult Emergency Department at the University of Maryland Medical Center.
—What is heat illness?
Children, seniors and people with chronic illnesses are most susceptible to heat illness, Gatz said, but anyone can be at risk if put in high-heat environments.
The lowest level of heat illness is heat exhaustion, which occurs when water and salt are depleted, typically from being outside and sweating. This can make people feel that they're going to pass out, their heart is beating faster or they feel nauseous, according to Cheyenne Falat, the assistant medical director of the Adult Emergency Department at the University of Maryland Medical Center.
At this stage, Falat said, getting hydrated, moving away from the heat and cooling the body can usually be enough to prevent serious illness.
Moderate heat illness can include heat rash, swelling — typically in the legs — and heat cramps and brief fainting, Falat said.
The most severe level of heat illness is heat stroke, which affects the neurological system. Falat said looking out for any changes like slurred speech, difficulties with fine motor skills, and being unsteady could be signs to head to see a medical professional as soon as possible.
'The earlier you can recognize it and intervene, the more you can prevent it from transitioning to that next stage,' Falat said.
Recognizing when heat illness is severe enough to warrant a trip to the hospital is challenging, however, Gatz said, but the most important step is listening to your body. To prevent heat illness, Falat and Gatz recommend attempting not to over-exert, applying sunscreen, hydrating and limiting time exposed to extreme temperatures.
—Heat in the workplace
Heat illness and heat-related deaths in Maryland have become top-of-mind for employers because of a new law requiring workplaces with high heat indexes to educate their employees on heat illness as well as provide water and frequent breaks.
The 2024 death of Baltimore City Department of Public Works trash collector Ronald Silver also ignited conversations in the region about monitoring the health of people working during high heat indexes.
The Maryland Department of Labor has not received any notifications of heat-related deaths at workplaces this year, a spokesperson for the department told the Sun. Maryland Occupational Safety and Health, part of the state labor department, has received reports of heat-related concerns that are being investigated, the spokesperson said, but did not specify the number of complaints.
AFSCME Maryland Council 3 — a union representing state, municipal and county employees in Maryland, of which Silver was a member — has also not heard any reports of heat-related deaths at workplaces in the state. Still, leaders do have concerns over a lack of heat safety plans from some of their employers, according to a union spokesperson. The plans are required under the heat safety standards, which became law in September 2024.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
22 minutes ago
- Yahoo
"It was kind of challenging but it was all for the good" - Luka Doncic reveals he gave up basketball to improve his conditioning for the next season
"It was kind of challenging but it was all for the good" - Luka Doncic reveals he gave up basketball to improve his conditioning for the next season originally appeared on Basketball Network. By now, the whole world has seen the transformation that Luka Doncic has made in his body in his first offseason as a Los Angeles Laker. This has not only surprised the consensus but also instilled belief that the 26-year-old superstar might just put together his best basketball season in his remarkable career so far. But ironically, what also led to Doncic's weight loss this summer wasn't basketball. In fact, the Slovenian sensation revealed that he had to be forced to stay away from it and take a whole new approach this offseason in order to achieve his goals. "I would say me and my team just tried different new things. Different food, different practices," he said. "I actually gave up playing basketball for one month, which I've never done in my life. So it was kind of challenging, but it was all good," said Doncic in his appearance on The Today's Show. Out with the old, in with the new While losing what seems to be more than 10 pounds, the 6'7" guard pursued playing other sports religiously, such as pickleball and padel. Doncic said that it helped that he played multiple sports as a kid growing up, which was why he eventually made peace with the fact that he wouldn't play basketball for a month. Instead of playing basketball, the international superstar focused on getting his diet right and placing more emphasis on weight training. Without playing basketball for the first time in years, the five-time All-Star also let his body recover completely, especially after a season that saw him miss 32 regular-season games because of a severe calf injury. This offseason, Doncic made it a point to lose weight, build muscle strength, and get right mentally. "This year, with my team, I think we did a huge step. But this is just the start, you know. I need to keep going. Can't stop," Doncic told Men's Health Magazine earlier this week. In prime position to bounce back Doncic also said he didn't lose weight to prove a point against his many critics who have long called him out for being out of shape. Instead, he did it for himself because he knows he needs to take advantage of his prime years while they're still around. It also helps that he's never been doubted the way he was last season, when not only the Dallas Mavericks traded him to the Lakers, but his early playoff exit led him to be more motivated than ever to come back stronger. "Honestly, I tried to not read much. Just tried to focus," he said about his critics. "I think I was still a pretty good basketball player back then, no matter what people say." True enough, an "out-of-shape" Doncic has averaged 28.6 points, 8.6 rebounds, and 8.2 assists thus far in his seven-year stint in the NBA. If he was able to be a top five player over the last couple of years, what more now with his change in approach in regards to his fitness? Time will eventually tell how monumental this summer would eventually end up impacting The Don's career moving story was originally reported by Basketball Network on Jul 31, 2025, where it first appeared.
Yahoo
an hour ago
- Yahoo
Why Novo Nordisk Stock Bumped Higher on Friday
Key Points The Federal government might boost its support of weight-loss drugs soon. According to a media report, it's contemplating a five-year, experimental program that would subsidize their costs for qualifying patients. 10 stocks we like better than Novo Nordisk › Unexpected news of a potential support program from the federal government boosted the share prices of weight-loss drug developers on Friday. The poster boy for that still rather small group, Wegovy/Ozempic maker Novo Nordisk (NYSE: NVO), understandably saw a stock price lift that day. It rose by more than 2%, contrasting well with the 1.6% slide of the S&P 500 index. Federal help for obesity drugs? That news came from The Washington Post, which published an article stating that the Trump administration is planning an experimental program that would cover the costs of such medications. Citing documents from the Centers for Medicare and Medicaid Services (CMS) it had obtained, the newspaper said the plan would be implemented by state Medicaid administrations. It would also be utilized by Medicare Part D insurance plans. These entities would be allowed to cover weight-loss drugs for qualifying patients. At the moment, Medicare generally covers such treatments for patients who suffer from type 2 diabetes. Both Novo Nordisk's Wegovy and rival Eli Lilly's Zepbound are essentially versions of predecessor diabetes drugs. Some private insurance plans cover obesity medications. The Post wrote that the experimental program will last for five years. Massive potential impact Novo Nordisk hasn't yet commented on the article, but we can be sure the company is excited about the prospect. Combined, Medicare and Medicaid are immense programs. Even if only a few states are willing to cover weight-loss treatments through them, the company could experience a surge in sales. For the stock's investors, this is a potentially very impactful development well worth monitoring. Should you buy stock in Novo Nordisk right now? Before you buy stock in Novo Nordisk, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Novo Nordisk wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $625,254!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,090,257!* Now, it's worth noting Stock Advisor's total average return is 1,036% — a market-crushing outperformance compared to 181% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 29, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. Why Novo Nordisk Stock Bumped Higher on Friday was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Addus HomeCare (ADUS) Q2 Earnings: What To Expect
Home healthcare provider Addus HomeCare (NASDAQ:ADUS) will be reporting results this Monday afternoon. Here's what you need to know. Addus HomeCare missed analysts' revenue expectations by 0.6% last quarter, reporting revenues of $337.7 million, up 20.3% year on year. It was a mixed quarter for the company, with a narrow beat of analysts' sales volume estimates. Is Addus HomeCare a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Addus HomeCare's revenue to grow 20.8% year on year to $346.5 million, improving from the 10.4% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.46 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Addus HomeCare has missed Wall Street's revenue estimates three times over the last two years. Looking at Addus HomeCare's peers in the senior health, home health & hospice segment, some have already reported their Q2 results, giving us a hint as to what we can expect. BrightSpring Health Services delivered year-on-year revenue growth of 15.3%, beating analysts' expectations by 5.2%, and Option Care Health reported revenues up 15.4%, topping estimates by 4.6%. Option Care Health traded down 2.7% following the results. Read our full analysis of BrightSpring Health Services's results here and Option Care Health's results here. The euphoria surrounding Trump's November win lit a fire under major indices, but potential tariffs have caused the market to do a 180 in 2025. While some of the senior health, home health & hospice stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 4.3% on average over the last month. Addus HomeCare is down 5.3% during the same time and is heading into earnings with an average analyst price target of $136.45 (compared to the current share price of $104.74). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data